Adicet Bio (ACET) Other Working Capital Changes (2018 - 2022)
Adicet Bio (ACET) posted quarterly Other Working Capital Changes of -$4.8 million for Q1 2022, up 9.05% quarter-over-quarter from -$5.3 million in Q4 2021.
Adicet Bio (ACET) Other Working Capital Changes (2018 - 2022) Analysis & Trends
Adicet Bio's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$4.8 million for Q1 2022.
- In Q1 2022, Other Working Capital Changes changed N/A year-over-year to -$4.8 million; the TTM figure through Dec 2022 stood at -$4.8 million (up 71.36% YoY), while the FY2022 annual figure was -$4.8 million, up 47.63% from the prior year.
- Other Working Capital Changes for Q1 2022 stood at -$4.8 million, up from -$5.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.5 million in Q3 2024, with the low at -$2.0 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$361000.0 (2022), against an average of -$256588.2.
- The sharpest annual moves came in 2019 and 2021: Other Working Capital Changes jumped 46.51% in 2019, then tumbled 472.85% in 2021.
- Adicet Bio's Other Working Capital Changes stood at -$3.7 million in 2018, then surged by 46.51% to -$2.0 million in 2019, then slumped by 301.42% to -$7.9 million in 2020, then soared by 33.16% to -$5.3 million in 2021, then gained by 9.05% to -$4.8 million in 2022.
- Business Quant data shows ACET's Other Working Capital Changes at -$4.8 million in Q1 2022, -$5.3 million in Q4 2021, and -$3.1 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Adicet Bio | 102.03 Mn | -16.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -4.81 Mn |
| Mar 31, 2022 | -4.81 Mn |
| Mar 31, 2022 | -4.81 Mn |
| Dec 31, 2021 | -5.28 Mn |
| Dec 31, 2021 | -5.28 Mn |
| Dec 31, 2021 | -5.28 Mn |
| Sep 30, 2021 | -3.06 Mn |
| Sep 30, 2021 | -3.06 Mn |
| Sep 30, 2021 | -3.06 Mn |
| Dec 31, 2020 | -7.90 Mn |
| Dec 31, 2020 | -7.90 Mn |
| Dec 31, 2020 | -7.90 Mn |
| Sep 30, 2020 | -534,000.00 |
| Sep 30, 2020 | -534,000.00 |
| Sep 30, 2020 | -534,000.00 |
| Jun 30, 2020 | 2.54 Mn |
| Jun 30, 2020 | 2.54 Mn |
| Jun 30, 2020 | 2.54 Mn |
| Mar 31, 2020 | -2.00 Mn |
| Mar 31, 2020 | -2.00 Mn |